Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/30974
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tesch G.H. | en |
dc.date.accessioned | 2021-05-14T10:28:29Z | en |
dc.date.available | 2021-05-14T10:28:29Z | en |
dc.date.copyright | 2010 | en |
dc.date.created | 20100705 | en |
dc.date.issued | 2012-10-12 | en |
dc.identifier.citation | Seminars in Nephrology. 30 (3) (pp 290-301), 2010. Date of Publication: May 2010. | en |
dc.identifier.issn | 0270-9295 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/30974 | en |
dc.description.abstract | Evidence from renal biopsies has shown that macrophage accumulation in diabetic kidneys predicts declining renal function, suggesting a pathogenic role for these cells in diabetic nephropathy. Further evidence from animal models has shown that macrophages are the major immune cells infiltrating the kidney in type 1 and type 2 diabetes, and that they contribute to the development of renal injury and sclerosis. This review examines macrophages in human and experimental diabetic nephropathy, exploring the mechanisms of macrophage recruitment and activation, and the process of macrophage-mediated injury in diabetic kidneys. The ability of current therapies and novel anti-inflammatory treatments to reduce macrophage-mediated injury in diabetic kidneys also is considered, which has important implications for the future management of patients with diabetic nephropathy. © 2010 Elsevier Inc. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | W.B. Saunders (Independence Square West, Philadelphia PA 19106-3399, United States) | en |
dc.title | Macrophages and diabetic nephropathy. | en |
dc.type | Article | en |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.semnephrol.2010.03.007 | en |
dc.publisher.place | United States | en |
dc.identifier.pubmedid | 20620673 [http://www.ncbi.nlm.nih.gov/pubmed/?term=20620673] | en |
dc.identifier.source | 359061175 | en |
dc.identifier.institution | (Tesch) Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia | en |
dc.description.address | G.H. Tesch, Department of Nephrology, Monash Medical Centre, 246 Clayton Rd, Clayton, VIC 3168, Australia. E-mail: greg.tesch@med.monash.edu.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2012 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Chemokines Diabetic nephropathy Fibrosis Inflammation Macrophages | en |
dc.identifier.authoremail | Tesch G.H.; greg.tesch@med.monash.edu.au | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.